Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.

Al-Laith M, Jasenecova M, Abraham S, Bosworth A, Bruce IN, Buckley CD, Ciurtin C, D'Agostino MA, Emery P, Gaston H, Isaacs JD, Filer A, Fisher BA, Huizinga TWJ, Ho P, Jacklin C, Lempp H, McInnes IB, Pratt AG, Östor A, Raza K, Taylor PC, van Schaardenburg D, Shivapatham D, Wright AJ, Vasconcelos JC, Kelly J, Murphy C, Prevost AT, Cope AP

Open source

DOI: 10.1186/s13063-019-3403-7
Published: 2019 Jul 15
Container: Trials
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13063-019-3403-7,
  title = {Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.},
  author = {Al-Laith M and Jasenecova M and Abraham S and Bosworth A and Bruce IN and Buckley CD and Ciurtin C and D'Agostino MA and Emery P and Gaston H and Isaacs JD and Filer A and Fisher BA and Huizinga TWJ and Ho P and Jacklin C and Lempp H and McInnes IB and Pratt AG and Östor A and Raza K and Taylor PC and van Schaardenburg D and Shivapatham D and Wright AJ and Vasconcelos JC and Kelly J and Murphy C and Prevost AT and Cope AP},
  year = {2019},
  journal = {Trials},
  doi = {10.1186/s13063-019-3403-7},
  url = {https://doi.org/10.1186/s13063-019-3403-7}
}

RIS

TY  - JOUR
TI  - Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.
AU  - Al-Laith M
AU  - Jasenecova M
AU  - Abraham S
AU  - Bosworth A
AU  - Bruce IN
AU  - Buckley CD
AU  - Ciurtin C
AU  - D'Agostino MA
AU  - Emery P
AU  - Gaston H
AU  - Isaacs JD
AU  - Filer A
AU  - Fisher BA
AU  - Huizinga TWJ
AU  - Ho P
AU  - Jacklin C
AU  - Lempp H
AU  - McInnes IB
AU  - Pratt AG
AU  - Östor A
AU  - Raza K
AU  - Taylor PC
AU  - van Schaardenburg D
AU  - Shivapatham D
AU  - Wright AJ
AU  - Vasconcelos JC
AU  - Kelly J
AU  - Murphy C
AU  - Prevost AT
AU  - Cope AP
PY  - 2019
JO  - Trials
DO  - 10.1186/s13063-019-3403-7
UR  - https://doi.org/10.1186/s13063-019-3403-7
ER  -

APA

M, A., M, J., S, A., A, B., IN, B., CD, B., C, C., MA, D., P, E., H, G., JD, I., A, F., BA, F., TWJ, H., P, H., C, J., H, L., IB, M., AG, P., A, Ö., K, R., PC, T., D, V. S., D, S., AJ, W., JC, V., J, K., C, M., AT, P., & AP, C. (2019). Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.. Trials. https://doi.org/10.1186/s13063-019-3403-7

Source records

pubmed · retrieved 2026-09-26T22:10:07.424Z